Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

Int J Gynecol Cancer. 2021 Jun;31(6):914-919. doi: 10.1136/ijgc-2020-001942. Epub 2020 Oct 5.


The SARS-CoV-2 (COVID-19) pandemic has significantly impacted the management of patients with gynecologic cancers. Many centers have reduced access to routine visits to avoid crowded waiting areas and specially to reduce the infection risk for oncologic patients. The goal of this review is to propose a surveillance algorithm for patients with gynecologic cancers during the COVID-19 pandemic based on existing evidence and established guidelines. It is time to consider strategies based on telemedicine and to adapt protocols in this new era. We hereby propose a strategy for routine surveillance both during and beyond the pandemic.

Keywords: cervical cancer; endometrial neoplasms; gynecology; ovarian cancer.

Publication types

  • Review

MeSH terms

  • Algorithms
  • COVID-19 / epidemiology*
  • Female
  • Genital Neoplasms, Female / diagnosis
  • Genital Neoplasms, Female / epidemiology*
  • Genital Neoplasms, Female / therapy
  • Humans
  • SARS-CoV-2 / isolation & purification
  • Telemedicine / methods*